RFQ-NIAID-24-2218371 - Attachment 1 - Bill of Materials (BOM).pdf

This document is a Request for Quotation (RFQ) for a mid-throughput Next Generation Sequencing (NGS) system and optional maintenance agreement. The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC), Vaccine Immunology Program (VIP) is seeking to acquire one (1) mid-throughput NGS system to support critical vaccine research and development. The required system must be an Illumina NextSeq 2000 or equal, with specific technical requirements outlined. The maintenance agreement option includes full coverage for parts, labor, travel, priority response, and software/hardware updates. Quotes are due by September 5, 2024, and the government anticipates making a single firm fixed price award. The period of performance is estimated to be August 20, 2024 - August 19, 2025, including a 12-month warranty. A 12-month service plan option may be exercised following the warranty period. This is an unrestricted procurement under NAICS code 334516, Analytical Laboratory Instrument Manufacturing.